CALCINATE Tablet

Calcium Carbonate
600 mg
ABBOTT S.p.A.
Pack size 1 Tablet Container (60 Tablets)
Dispensing mode
Source
Agent
Retail Price 0.50 AED

Indications

CALCINATE Tablet is used for: Heartburn, Indigestion, Calcium deficiency, Hypocalcaemia, Hyperphosphatemia, Calcium supplement, Stomach upset

Adult Dose

Adult: PO Hyperacidity: Take 1-2 tab as needed, up to a max of 16 tab/day. May suck or chew tablets. Hyperphosphataemia in chronic renal failure Initial: 2.5 g/day, up to 17 g/day in divided doses.

Child Dose

Renal Dose

Renal impairment: CrCl (ml/min) <25 Dosage adjustments may be needed depending on serum calcium levels.

Administration

May be taken with or without food. Take w/ meals for better absorption. Avoid taking w/ large amount of fibre-rich food.

Contra Indications

Patients with Ca renal calculi or history of renal calculi; hypercalcaemia; hypophosphataemia. Patients with suspected digoxin toxicity.

Precautions

Renal impairment, hypoparathyroid disease, hypercalcaemia-associated diseases. Calcium absorption is impaired in achlorhydria; use an alternate salt and take with food. Caution when used in patients with a history of kidney stones. Lactation: Safe; crosses the placenta; appears in breast milk

Pregnancy-Lactation

Pregnancy category: C Lactation: Safe; crosses the placenta; appears in breast milk

Interactions

Co-administration with thiazide diuretics or vit D may lead to milk-alkali syndrome and hypercalcaemia. Decreased absorption with corticosteroids. Decreases absorption of tetracyclines, atenolol, iron, quinolones, alendronate, Na fluoride, Zn and calcium-channel blockers. Enhances cardiac effects of digitalis glycosides and may precipitate digitalis intoxication.

Adverse Effects

Side effects of Calcium Carbonate : Anorexia, nausea, vomiting, constipation, flatulence; hypercalcaemia; metabolic alkalosis; milk-alkali syndrome, tissue-calcification. Gastric hypersecretion and acid rebound (with prolonged use).

Mechanism of Action

Calcium carbonate can neutralise gastric acid rapidly and effectively. However, it may adversely activate Ca dependent processes, leading to secretion of gastric and hydrochloric acid. It can induce rebound acid secretion and, prolonged high doses may cause hypercalcemia, alkalosis and milk-alkali syndrome.

Note

CALCINATE 600 mg Tablet manufactured by ABBOTT S.p.A.. Its generic name is Calcium Carbonate. CALCINATE is availble in Saudi Arabia. Farmaco SA drug index information on CALCINATE Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Calcium Carbonate :